Today, over 500,000 medical technologies are available in hospitals, homes, and community care settings. They range from simple bandages to complex, multi-part body scanners that cost millions of dollars to develop. Yet a typical technology has a lifecycle of just 21 months before an improved product usurps it—the healthcare ecosystem is rapidly advancing and driven by a constant flow of innovation. And those innovations need innovators. With $21 billion made available for investment in the digital healthcare industry in 2020 (a 20x increase on 2010), entrepreneurs, investors, and related actors are entering the healthcare ecosystem in greater numbers than ever before. Last year alone, over 17,000 medical technology patents were filed, the third highest of all patent types. Each of those has a dedicated team of entrepreneurs behind it. Yet with increasingly strict regulations and pharmaceutical giants growing more aggressive, many thousands of entrepreneurs fail before even the patent stage: just 2% secure revenue or adoption. Healthtech Innovation: How Entrepreneurs Can Define and Build the Value of Their New Products is a down-to-earth survival guide for entrepreneurs struggling to secure a strategic position within the healthtech ecosystem. Which is expected that by 2026, the global digital health market size will be around $657 billion. This book is designed to help innovators navigate this complex and newly volatile landscape. It covers business strategy, marketing, funding acquisition, and operation in a global regulatory context. It is written in simple language, evidenced by the latest academic and industry research, and explained using real-world examples and case studies.

Health Tech: Rebooting Society's Software, Hardware and Mindset fulfills the need for actionable insight on what's truly driving change and how to become a changemaker, not just affected by it. The book introduces anybody who wishes to understand how global healthcare will change in the next decade to the key technologies, social dynamics, and systemic shifts that are shaping the future. Healthcare futurist, investor, and entrepreneur Trond Arne Undheim describes the complex history of public health, why it's so complicated and what the major challenges are right now. He includes a discussion of COVID, why it happened, the cultural factors that have slowed down traditional public health measures, and how innovation can help. He also discusses what is happening in health systems around the world as a result of the pandemic. The book explores certain health tech measures, tools (basic medical devices gradually being upgraded and digitally enhanced), processes, and innovations that are already working well along with others that are in their infancy, such as AI, wearables, robotics, sensors, and digital therapeutics. The book describes the movers and shakers in the healthcare system of the future, from startups to patient and service providers, as well as the health challenges of our time, including pandemics, aging, preventive healthcare, and much more. The book concludes with a look at how health tech may bring about the biggest opportunity to transform healthcare for decades to come.

This comprehensive book provides a detailed survey and practical examination of a wide range of legal and regulatory topics in HealthTech. Key features include: • Analysis of the impact of emerging innovations on the accessibility, efficiency and quality of healthcare and its effects on healthcare providers • Examination of artificial intelligence, blockchain and digital identity applications in healthcare, alongside associated regulatory challenges • Guidance on the financial requirements of healthcare start-ups at different stages of growth and various collaboration and partnership models in the HealthTech market • Discussion of the major regulatory questions affecting the HealthTech industry, from data protection, public procurement and product liability, to the regulation of medical devices, intellectual property and advertising.

Follows the scheme of financial analyst Cary Cimino as he embarked on an illegal operation, which was supported by organized crime families, to make millions of dollars from naive stockbrokers and investors.

Each issue is packed with extensive news about important cancer related science, policy, politics and people. Plus, there are editorials and reviews by experts in the field, book reviews, and commentary on timely topics.